|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00701402 |
|
Date of registration:
|
18/06/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
National Survey on Dyslipidemic Patients
PRYSME |
|
Scientific title:
|
Survey on Time to Lipid-lowering Drug Implementation on Dyslipidemic Patients in General Practice. |
|
Date of first enrolment:
|
June 2008 |
|
Target sample size:
|
3655 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00701402 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Cross-Sectional
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Alain Castaigne |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
AstraZeneca |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosis of dyslipemia made less than 2 years
- Treated by a lipid-lowering drug
- Agree to take part in the survey
Exclusion Criteria:
- Patient included in a clinical trial
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Dyslipidemia
|
|
Primary Outcome(s)
|
|
time to lipid-lowering drug implementation (immediately, treatment within a period 0-3 month and > 3 month, according to the cardiovascular risk level, (0 risk factor, 1 risk factor, 2 risk factors, = 3 risk factors, secondary prevention).
[Time Frame: Once]
|
|
Secondary ID(s)
|
|
NIS-CFR-DUM-2007/9
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|